| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.01 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.01 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.075 | 0.01 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.01 |